Daewoong's Q1 sales grew up with Gasmotin and Nicostop.

Published: 2005-08-16 06:58:00

Updated: 2005-08-16 06:58:00

Daewoong reported 80,238 million won of sales during the Q1 of 2005 (April to June 2005), which was nearly 10 billion won of increase over the same period of last year, 9,784 MW of operating income, 8,784 MW of ordinary income and 6,368 MW of net income.

By product, the sales showed 6,245 MW ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK